Polymorphic repeat in AIB1 does not alter breast cancer risk

AUTOR(ES)

Haiman, Christopher A

FONTE

BioMed Central

RESUMO

We assessed the association between a glutamine repeat polymorphism in AIB1 and breast cancer risk in a case-control study (464 cases, 624 controls) nested within the Nurses' Health Study cohort. We observed no association between AIB1 genotype and breast cancer incidence, or specific tumor characteristics. These findings suggest that AIB1 repeat genotype does not influence postmenopausal breast cancer risk among Caucasian women in the general population.

Documentos Relacionados

• Phenotypic alterations in breast cancer cells overexpressing the nuclear receptor co-activator AIB1
• Endogenously expressed estrogen receptor and coactivator AIB1 interact in MCF-7 human breast cancer cells
• Abortion does not raise risk of breast cancer, US study finds
• Does diet affect breast cancer risk?
• Coactivator AIB1 links estrogen receptor transcriptional activity and stability